Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:2260-2265
Published online before print August 10, 2006, doi: 10.1161/01.STR.0000238584.57864.d4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/9/2260    most recent
01.STR.0000238584.57864.d4v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iglseder, B.
Right arrow Articles by Patsch, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iglseder, B.
Right arrow Articles by Patsch, W.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Related Collections
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Energy metabolism
Right arrow Gene regulation
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Risk Factors for Stroke
Right arrow Mechanism of atherosclerosis/growth factors

(Stroke. 2006;37:2260.)
© 2006 American Heart Association, Inc.


Original Contributions

Associations of PPARGC1A Haplotypes With Plaque Score but Not With Intima-Media Thickness of Carotid Arteries in Middle-Aged Subjects

Bernhard Iglseder, MD; Hannes Oberkofler, PhD; Thomas K. Felder, PhD; Kerstin Klein, PhD; Bernhard Paulweber, PhD; Franz Krempler, MD; David A. Tregouet, PhD Wolfgang Patsch, MD

From the Paracelsus Private Medical University (B.I., H.O., T.K.F., K.K., B.P., W.P.), Salzburg; Krankenhaus Hallein (F.K.), Hallein, Austria; and INSERM, U525, Université Pierre et Marie Curie, Faculté de Médecine Pitié-Salpêtrière (D.A.T.), Paris, France.

Correspondence to Wolfgang Patsch, MD, Paracelsus Private Medical University and Landeskliniken Salzburg, Muellner Hauptstrasse 48, A-5020 Salzburg. E-mail w.patsch{at}salk.at

Background and Purpose— Peroxisome proliferator activated receptor {gamma} coactivator 1{alpha} (PGC-1{alpha}, PPARGC1A) integrates the transcriptional program of mitochondrial biogenesis. Mitochondria are the main source of cellular reactive oxygen species implicated in atherogenesis. We therefore ascertained associations of PPARGC1A polymorphisms with asymptomatic carotid atherosclerosis.

Methods— Eight single nucleotide polymorphisms tagging two haplotype blocks within PPARGC1A were studied in 1379 participants of the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk. Early atherosclerosis was assessed by intima-media thickness and extent of plaques (B-score) of the carotid arteries.

Results— No associations of carotid artery intima-media thickness measurements with block 1 or 2 haplotype distributions or individual haplotypes were observed. However, the block 1 haplotype carrying the variant C nucleotide at –3974 relative to the transcription start site was associated with disease status defined by the presence of more than one minimal lesion and the –3974 C allele was associated with decreased risk (odds ratio=0.60, P=0.007) after adjustment for linkage disequilibrium between single nucleotide polymorphisms.

Conclusions— These result are consistent with the concept that risk factors for distinct carotid phenotypes may vary and suggest, but do not prove, that PGC-1{alpha} may contribute to the regulation of atherogenic pathways.


Key Words: carotid atherosclerosis • haplotype • peroxisome proliferator activated receptor gamma coactivator • reactive oxygen species